Profile
Company facts
- Exchange
- SHG
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- CNE1000030C3
- Market cap
- 4B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.69
About
About Thalys Medical Technology Group Inc
Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.
Visit company website
5 years, 4 months ago
Thalys Medical Technology Group Inc is currently in a long term downtrend where the price is trading 9.6% below its 200 day moving average.
From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Thalys Medical Technology Group Inc's total revenue rose by 25.0% to $585M since the same quarter in the previous year.
Its net income has dropped by 35.5% to $21M since the same quarter in the previous year.
Finally, its free cash flow fell by 2593.1% to $-102M since the same quarter in the previous year.
Based on the above factors, Thalys Medical Technology Group Inc gets an overall score of 2/5.